Crohn's disease
ProciseDx Enters Markets for Inflammation, Medication Monitoring With Five-Minute POC Instrument
Premium
The firm has developed an instrument that uses fingerstick blood or stool samples to enable quantitative results for the management of conditions caused by inflammation.
The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end.
ProciseDx Gets CE Mark for Point-of-Care Inflammatory Bowel Disease Test
The fecal calprotectin test, which runs on the company's ProciseDx immunoassay system, is designed to help in the diagnosis of Crohn's disease and ulcerative colitis.
Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test
Adaptive is rebranding its immunoSeq Dx assay as T-Detect and plans to submit for an EUA for a COVID-19 T-Cell response test by the end of the year.
PredictImmune Inks Multinational Commercialization Pact for IBD Test
The test is designed to analyze the expression of 17 genes in order to differentiate mild and aggressive forms of Crohn's disease and ulcerative colitis.